FDA fines Red Cross for blood-safety violations

11/28/2006 | MSN Money

The American Red Cross is facing an additional $5.7 million fine for continued violations of blood-safety rules and failure to correct the unsafe practices, despite a 2003 agreement to do so. The Red Cross plans to formulate a new plan to comply with FDA regulatory concerns and has requested a thorough assessment of its compliance issues.

View Full Article in:

MSN Money

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA